Tapewire

NYSE · USD

CNMD

CONMED Corp

Export transactions ↓
Tapewire entity
4691
SEC CIK
0000816956
Parsed reports
532

Last 12 months

Inside the activity.

0 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 01, 2017 Filed Jun 2, 2017 16:01 UTC
Cohen Heather LEVP CORP HR
Tax withholdingCommon Stock 296 $51.90 $15,362.40
Disclosure

SEC source: 0001127602-17-020198 · form4.xml · nonDerivative · entry 2

Cohen Heather L · CIK 0001436649 · EVP CORP HR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,795

Read SEC document
June 01, 2017 Filed Jun 2, 2017 16:01 UTC
Cohen Heather LEVP CORP HR
Exercise / conversionCommon Stock 800 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-020198 · form4.xml · nonDerivative · entry 1

Cohen Heather L · CIK 0001436649 · EVP CORP HR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,091

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 15:55 UTC
Berge Terence MVP Corp. Treasurer
Exercise / conversionRsus (restricted Stock Units) · Derivative 520 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-17-020197 · form4.xml · derivative · entry 12

Berge Terence M · CIK 0001635424 · VP Corp. Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,040

Underlying: Common Stock · 520 shares

Expires 2024-06-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 15:55 UTC
Berge Terence MVP Corp. Treasurer
Exercise / conversionRsus (restricted Stock Units) · Derivative 800 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-17-020197 · form4.xml · derivative · entry 11

Berge Terence M · CIK 0001635424 · VP Corp. Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 800

Underlying: Common Stock · 800 shares

Expires 2023-06-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 15:55 UTC
Berge Terence MVP Corp. Treasurer
Exercise / conversionRsus (restricted Stock Units) · Derivative 800 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-17-020197 · form4.xml · derivative · entry 10

Berge Terence M · CIK 0001635424 · VP Corp. Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 800 shares

Expires 2022-06-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 15:55 UTC
Berge Terence MVP Corp. Treasurer
Exercise / conversionRsus (restricted Stock Units) · Derivative 600 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-17-020197 · form4.xml · derivative · entry 9

Berge Terence M · CIK 0001635424 · VP Corp. Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 600 shares

Expires 2020-06-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs vesting over a seven year period with 14% of the RSU's vesting in the first through the fifth year after the grant date and 15% vesting in the sixth and seventh year.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 15:55 UTC
Berge Terence MVP Corp. Treasurer
Tax withholdingCommon Stock 193 $51.90 $10,016.70
Disclosure

SEC source: 0001127602-17-020197 · form4.xml · nonDerivative · entry 8

Berge Terence M · CIK 0001635424 · VP Corp. Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,250

Read SEC document
June 01, 2017 Filed Jun 2, 2017 15:55 UTC
Berge Terence MVP Corp. Treasurer
Exercise / conversionCommon Stock 520 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-020197 · form4.xml · nonDerivative · entry 7

Berge Terence M · CIK 0001635424 · VP Corp. Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,443

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 15:55 UTC
Berge Terence MVP Corp. Treasurer
Tax withholdingCommon Stock 296 $51.90 $15,362.40
Disclosure

SEC source: 0001127602-17-020197 · form4.xml · nonDerivative · entry 6

Berge Terence M · CIK 0001635424 · VP Corp. Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,923

Read SEC document
June 01, 2017 Filed Jun 2, 2017 15:55 UTC
Berge Terence MVP Corp. Treasurer
Exercise / conversionCommon Stock 800 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-020197 · form4.xml · nonDerivative · entry 5

Berge Terence M · CIK 0001635424 · VP Corp. Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,219

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 15:55 UTC
Berge Terence MVP Corp. Treasurer
Tax withholdingCommon Stock 296 $51.90 $15,362.40
Disclosure

SEC source: 0001127602-17-020197 · form4.xml · nonDerivative · entry 4

Berge Terence M · CIK 0001635424 · VP Corp. Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,419

Read SEC document
June 01, 2017 Filed Jun 2, 2017 15:55 UTC
Berge Terence MVP Corp. Treasurer
Exercise / conversionCommon Stock 800 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-020197 · form4.xml · nonDerivative · entry 3

Berge Terence M · CIK 0001635424 · VP Corp. Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,715

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 15:55 UTC
Berge Terence MVP Corp. Treasurer
Tax withholdingCommon Stock 222 $51.90 $11,521.80
Disclosure

SEC source: 0001127602-17-020197 · form4.xml · nonDerivative · entry 2

Berge Terence M · CIK 0001635424 · VP Corp. Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,915

Read SEC document
June 01, 2017 Filed Jun 2, 2017 15:55 UTC
Berge Terence MVP Corp. Treasurer
Exercise / conversionCommon Stock 600 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-020197 · form4.xml · nonDerivative · entry 1

Berge Terence M · CIK 0001635424 · VP Corp. Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,137

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2017 Filed May 16, 2017 14:41 UTC
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
SaleCommon Stock 500 $51.00 $25,500.00
Disclosure

SEC source: 0001127602-17-018182 · form4.xml · nonDerivative · entry 2

JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,955

Read SEC document
May 15, 2017 Filed May 16, 2017 14:41 UTC
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
SaleCommon Stock 2,500 $51.26 $128,161.00
Disclosure

SEC source: 0001127602-17-018182 · form4.xml · nonDerivative · entry 1

JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,455

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.20 to $51.38. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.

Read SEC document
May 15, 2017 Filed May 16, 2017 14:34 UTC Exercise / conversionSars (Stock Appreciation Rights) · Derivative 2,500 $0.00 Strike: $30.04 $0.00
Disclosure

SEC source: 0001127602-17-018178 · form4.xml · derivative · entry 3

TRYNISKI MARK E · CIK 0001242753 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,500 shares

Expires 2017-05-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The stock appreciation rights ("SARs") were granted under the Company's 2007 Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 20% per year over a five year period, with any unvested SARs to vest upon the Director's termination of service provided the Director has completed one full year of service since the date of the award in which case the SARs shall be exercisable at any time prior to the expiration date of the SAR or within one year after the date of such termination, whichever period is shorter.

F1 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 2007 Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 20% per year over a five year period, with any unvested SARs to vest upon the Director's termination of service provided the Director has completed one full year of service since the date of the award in which case the SARs shall be exercisable at any time prior to the expiration date of the SAR or within one year after the date of such termination, whichever period is shorter.

Read SEC document
May 15, 2017 Filed May 16, 2017 14:34 UTC Tax withholdingCommon Stock 1,475 $50.94 $75,136.50
Disclosure

SEC source: 0001127602-17-018178 · form4.xml · nonDerivative · entry 2

TRYNISKI MARK E · CIK 0001242753 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,025

Read SEC document
May 15, 2017 Filed May 16, 2017 14:34 UTC Exercise / conversionCommon Stock 2,500 $30.04 $75,100.00
Disclosure

SEC source: 0001127602-17-018178 · form4.xml · nonDerivative · entry 1

TRYNISKI MARK E · CIK 0001242753 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 03, 2017 Filed Apr 4, 2017 19:05 UTC PurchaseCommon Stock 180 $44.41 $7,993.80
Disclosure

SEC source: 0001127602-17-013826 · form4.xml · nonDerivative · entry 1

Farkas Charles · CIK 0001615538 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,505

F1 · kind: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 27, 2017.

Read SEC document
March 31, 2017 Filed Apr 4, 2017 19:26 UTC
Peters Stanley W IIIVP GM Advanced Surgery
GrantCommon Stock 543 $42.19 $22,909.17
Disclosure

SEC source: 0001127602-17-013834 · form4.xml · nonDerivative · entry 1

Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,354

Read SEC document
March 31, 2017 Filed Apr 4, 2017 16:45 UTC
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
GrantCommon Stock 249 $42.19 $10,505.31
Disclosure

SEC source: 0001127602-17-013738 · form4.xml · nonDerivative · entry 1

JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,955

Read SEC document
March 15, 2017 Filed Mar 17, 2017 16:59 UTC
Cohen Heather LEVP CORP HR
Grant401 (K) Plan 4,867.0024 $42.45 $206,604.25
Disclosure

SEC source: 0001127602-17-012105 · form4.xml · nonDerivative · entry 1

Cohen Heather L · CIK 0001436649 · EVP CORP HR

10b5-1 filing: Not disclosed

Ownership: Indirect · 401 (K) Plan

Disclosed balance after: 4,867.0024

F1 · date: As of March 15, 2017.

F2 · shares: The 4867.0024 represents an approximate number of shares equivalent in a Company stock fund in the 401 (K) Plan.

Read SEC document
March 13, 2017 Filed Mar 14, 2017 16:22 UTC
Cohen Heather LEVP CORP HR
PurchaseCommon Stock 440 $40.00 $17,598.24
Disclosure

SEC source: 0001127602-17-011511 · form4.xml · nonDerivative · entry 1

Cohen Heather L · CIK 0001436649 · EVP CORP HR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,291

Read SEC document
March 10, 2017 Filed Mar 13, 2017 18:04 UTC
Hartman Curt RDirector · President & CEO
PurchaseCommon Stock 400 $40.14 $16,055.60
Disclosure

SEC source: 0001127602-17-011379 · form4.xml · nonDerivative · entry 3

Hartman Curt R · CIK 0001451535 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,500

Read SEC document
March 10, 2017 Filed Mar 13, 2017 18:04 UTC
Hartman Curt RDirector · President & CEO
PurchaseCommon Stock 2,630 $40.11 $105,484.83
Disclosure

SEC source: 0001127602-17-011379 · form4.xml · nonDerivative · entry 2

Hartman Curt R · CIK 0001451535 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,100

Read SEC document
March 10, 2017 Filed Mar 13, 2017 18:04 UTC
Hartman Curt RDirector · President & CEO
PurchaseCommon Stock 5,000 $40.12 $200,575.00
Disclosure

SEC source: 0001127602-17-011379 · form4.xml · nonDerivative · entry 1

Hartman Curt R · CIK 0001451535 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,470

Read SEC document
March 06, 2017 Filed Mar 7, 2017 14:37 UTC PurchaseCommon Stock 5,000 $41.15 $205,750.00
Disclosure

SEC source: 0001127602-17-010504 · form4.xml · nonDerivative · entry 1

TRYNISKI MARK E · CIK 0001242753 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $41.10 to $41.25, inclusive. Full information regarding the number of shares purchased at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

Read SEC document
March 01, 2017 Filed Mar 3, 2017 18:44 UTC
SHAGORY PETER KEVP, STRAT & CORP DEVT
GrantOptions To Purchase Common Stock · Derivative 24,000 $0.00 Strike: $41.93 $0.00
Disclosure

SEC source: 0001127602-17-010001 · form4.xml · derivative · entry 7

SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,000

Underlying: Common Stock · 24,000 shares

Expires 2027-03-01

F3 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period

Read SEC document
March 01, 2017 Filed Mar 3, 2017 18:44 UTC
SHAGORY PETER KEVP, STRAT & CORP DEVT
Exercise / conversionRsus (restricted Stock Units) · Derivative 300 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-17-010001 · form4.xml · derivative · entry 6

SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 900

Underlying: Common Stock · 300 shares

Expires 2026-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.

Read SEC document
March 01, 2017 Filed Mar 3, 2017 18:44 UTC
SHAGORY PETER KEVP, STRAT & CORP DEVT
Exercise / conversionRsus (restricted Stock Units) · Derivative 400 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-17-010001 · form4.xml · derivative · entry 5

SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 800

Underlying: Common Stock · 400 shares

Expires 2025-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.

Read SEC document
March 01, 2017 Filed Mar 3, 2017 18:44 UTC
SHAGORY PETER KEVP, STRAT & CORP DEVT
Tax withholdingCommon Stock 110 $41.93 $4,612.30
Disclosure

SEC source: 0001127602-17-010001 · form4.xml · nonDerivative · entry 4

SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 698

Read SEC document
March 01, 2017 Filed Mar 3, 2017 18:44 UTC
SHAGORY PETER KEVP, STRAT & CORP DEVT
Exercise / conversionCommon Stock 300 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-010001 · form4.xml · nonDerivative · entry 3

SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 808

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 01, 2017 Filed Mar 3, 2017 18:44 UTC
SHAGORY PETER KEVP, STRAT & CORP DEVT
Tax withholdingCommon Stock 146 $41.93 $6,121.78
Disclosure

SEC source: 0001127602-17-010001 · form4.xml · nonDerivative · entry 2

SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 508

Read SEC document
March 01, 2017 Filed Mar 3, 2017 18:44 UTC
SHAGORY PETER KEVP, STRAT & CORP DEVT
Exercise / conversionCommon Stock 400 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-010001 · form4.xml · nonDerivative · entry 1

SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 654

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 01, 2017 Filed Mar 3, 2017 19:38 UTC
Berge Terence MVP Corp. Treasurer
GrantOptions To Purchase Common Stock · Derivative 14,000 $0.00 Strike: $41.93 $0.00
Disclosure

SEC source: 0001127602-17-010026 · form4.xml · derivative · entry 7

Berge Terence M · CIK 0001635424 · VP Corp. Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,000

Underlying: Common Stock · 14,000 shares

Expires 2027-03-01

F3 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period

Read SEC document
March 01, 2017 Filed Mar 3, 2017 19:38 UTC
Berge Terence MVP Corp. Treasurer
Exercise / conversionRsus (restricted Stock Units) · Derivative 250 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-17-010026 · form4.xml · derivative · entry 6

Berge Terence M · CIK 0001635424 · VP Corp. Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 750

Underlying: Common Stock · 250 shares

Expires 2026-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.

Read SEC document
March 01, 2017 Filed Mar 3, 2017 19:38 UTC
Berge Terence MVP Corp. Treasurer
Exercise / conversionRsus (restricted Stock Units) · Derivative 300 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-17-010026 · form4.xml · derivative · entry 5

Berge Terence M · CIK 0001635424 · VP Corp. Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 600

Underlying: Common Stock · 300 shares

Expires 2025-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.

Read SEC document
March 01, 2017 Filed Mar 3, 2017 19:38 UTC
Berge Terence MVP Corp. Treasurer
Tax withholdingCommon Stock 91 $41.93 $3,815.63
Disclosure

SEC source: 0001127602-17-010026 · form4.xml · nonDerivative · entry 4

Berge Terence M · CIK 0001635424 · VP Corp. Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,537

Read SEC document
March 01, 2017 Filed Mar 3, 2017 19:38 UTC
Berge Terence MVP Corp. Treasurer
Exercise / conversionCommon Stock 250 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-010026 · form4.xml · nonDerivative · entry 3

Berge Terence M · CIK 0001635424 · VP Corp. Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,628

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 01, 2017 Filed Mar 3, 2017 19:38 UTC
Berge Terence MVP Corp. Treasurer
Tax withholdingCommon Stock 109 $41.93 $4,570.37
Disclosure

SEC source: 0001127602-17-010026 · form4.xml · nonDerivative · entry 2

Berge Terence M · CIK 0001635424 · VP Corp. Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,378

Read SEC document
March 01, 2017 Filed Mar 3, 2017 19:38 UTC
Berge Terence MVP Corp. Treasurer
Exercise / conversionCommon Stock 300 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-010026 · form4.xml · nonDerivative · entry 1

Berge Terence M · CIK 0001635424 · VP Corp. Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,487

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 01, 2017 Filed Mar 3, 2017 18:40 UTC
Ruiz-Caban WilfredoEVP QA, RA and Operations
GrantRsus (restricted Stock Units) · Derivative 1,600 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-17-009996 · form4.xml · derivative · entry 5

Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,600

Underlying: Common Stock · 1,600 shares

Expires 2027-03-01

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.

Read SEC document
March 01, 2017 Filed Mar 3, 2017 18:40 UTC
Ruiz-Caban WilfredoEVP QA, RA and Operations
GrantOptions To Purchase Common Stock · Derivative 30,000 $0.00 Strike: $41.93 $0.00
Disclosure

SEC source: 0001127602-17-009996 · form4.xml · derivative · entry 4

Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2027-03-01

F2 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period

Read SEC document
March 01, 2017 Filed Mar 3, 2017 18:40 UTC
Ruiz-Caban WilfredoEVP QA, RA and Operations
Exercise / conversionRsus (restricted Stock Units) · Derivative 375 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-17-009996 · form4.xml · derivative · entry 3

Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,125

Underlying: Common Stock · 375 shares

Expires 2026-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.

Read SEC document
March 01, 2017 Filed Mar 3, 2017 18:40 UTC
Ruiz-Caban WilfredoEVP QA, RA and Operations
Tax withholdingCommon Stock 142 $41.93 $5,954.06
Disclosure

SEC source: 0001127602-17-009996 · form4.xml · nonDerivative · entry 2

Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 233

Read SEC document
March 01, 2017 Filed Mar 3, 2017 18:40 UTC
Ruiz-Caban WilfredoEVP QA, RA and Operations
Exercise / conversionCommon Stock 375 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-009996 · form4.xml · nonDerivative · entry 1

Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 375

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 01, 2017 Filed Mar 3, 2017 18:29 UTC
Folkert NathanVP GM Orthopedics
GrantRsus (restricted Stock Units) · Derivative 1,600 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-17-009986 · form4.xml · derivative · entry 5

Folkert Nathan · CIK 0001654392 · VP GM Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,600

Underlying: Common Stock · 1,600 shares

Expires 2027-03-01

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.

Read SEC document
March 01, 2017 Filed Mar 3, 2017 18:29 UTC
Folkert NathanVP GM Orthopedics
GrantOptions To Purchase Common Stock · Derivative 36,000 $0.00 Strike: $41.93 $0.00
Disclosure

SEC source: 0001127602-17-009986 · form4.xml · derivative · entry 4

Folkert Nathan · CIK 0001654392 · VP GM Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,000

Underlying: Common Stock · 36,000 shares

Expires 2027-03-01

F2 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period

Read SEC document
March 01, 2017 Filed Mar 3, 2017 18:29 UTC
Folkert NathanVP GM Orthopedics
Exercise / conversionRsus (restricted Stock Units) · Derivative 500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-17-009986 · form4.xml · derivative · entry 3

Folkert Nathan · CIK 0001654392 · VP GM Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,500

Underlying: Common Stock · 500 shares

Expires 2026-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.